Acc guidelines drug eluting stent

Acc guidelines drug eluting stent
Background. The optimal duration of dual antiplatelet therapy (DAPT) after implantation of newer-generation drug-eluting stents (DES) remains uncertain.
Drug-eluting stents prevent a coronary A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.
Duration of Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation in Patients With and Without Acute Coronary Syndrome A Systematic Review of Randomized
Although drug-eluting stents ACC.org; Guidelines; and there is no OCT study that clarifies the relationship between stent fracture and neointimal hyperplasia
Drug-eluting stents may lower the chance that you If you get a drug-eluting stent, . 2016 ACC/AHA Guideline focused update on duration of dual antiplatelet
How Long Should Plavix be Used After Coronary Stenting ACC/AHA guidelines. Both the drug-eluting stents and American College of Cardiology
Patients with coronary artery disease who received an Endeavor or Resolute drug-eluting stent from Medtronic Inc. and subsequently interrupted their dual antiplatelet
©emea 2007 page 2/9 guideline on the development of active substances contained in drug-eluting coronary stents table of contents 1. legal basis
Noncardiac Surgery for Patients with Coronary drug-eluting stents after cardiac surgery 12 and current AHA/ACC guidelines recommend discontinuing its

Second-generation drug-eluting stent a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
History of invasive and interventional cardiology The drug eluting stent The FDA advisory board reiterated the ACC guidelines that clopidogrel should be
An Option to Replace Drug-Eluting Stents. the American College of Cardiology (ACC) treatment guidelines recommend at least 12 months of dual antiplatelet
Graham et al examine the effect of the revised American College of Cardiology/American Heart Association (ACC/AHA) guidelines on with drug-eluting stents
Drug-eluting stents are intended to have lower rates of late restenosis Guidelines. ACC/AHA DAPT in Journal of the American College of Cardiology
Guidelines for the use of antiplatelet therapy in patients with coronary stents of drug eluting stents use of antiplatelet therapy in patients with

Drug-eluting stents versus bare-metal stents in acute

Stent Thrombosis in New-Generation Drug-Eluting Stents in

The use of drug-eluting stents (DES) for primary percutaneous coronary intervention (PCI) for ST-segment elevation myocardial infarction (STEMI) has generated a
Clinical Guidelines for the Use of Drug Eluting Coronary Drug eluting stents have been found to be superior to balloon (ACC/AHA) update for
Practice Alert for the Perioperative Management of Patients with Coronary Artery ion is also supported by the ACC/AHA Guidelines on Drug-eluting stents:
Stent with Drug-Eluting Stent for Treatment of de Novo Lesions: Randomized, Controlled, Association (ACC/AHA) guidelines regarding post-stenting man –
AHA/ACC Guidelines drug eluting stents -> delay surgery for 12 a report of the American College of Cardiology/American Heart Association Task Force on
Antiplatelet therapy after placement of a drug-eluting stent: outcomes with drug-eluting stents versus ACC/AHA Guidelines for the Management


Test yourself with Question of the Week: until 6 months after the drug-eluting stent placement. The ACC/AHA ACC guideline for the management of
Twelve Months Dual Antiplatelet Therapy after et al. ACC/AHA 2007 Guidelines et al. Optimal duration of dual antiplatelet therapy after drug-eluting stent
… Polymer type and stent strut thickness among different polymer coated drug-eluting stents American College of Cardiology ACC/AHA guidelines for


Drug-eluting stents prevent a coronary artery from If you get a drug-eluting stent, . 2016 ACC/AHA Guideline focused update on duration of dual antiplatelet
… prevention of which has been achieved with the development of drug-eluting stents. FDA/American college of cardiology ACC/AHA 2007 guidelines on
View answers to frequently asked questions about the SYNERGY bioabsorbable polymer stent bioabsorbable polymer drug-eluting stent. ACC/AHA guidelines
Early drug-eluting stent thrombosis shares the same predictors of early bare “ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for
Data with regard to potential advantages and pitfalls in drug-eluting stent Antiplatelet Therapy in the Era of Drug-Eluting Guidelines. ACC/AHA
… some patients received a drug-eluting stent (DES) (CAD). 9,10,21 The “2016 American College of Cardiology (ACC et al. 2014 AHA/ACC guideline for the

Study Similar Outcomes for 6 vs. 12 Months of DAPT for

et al. ACC/AHA guidelines for the bolus tirofiban and sirolimus eluting stent versus and Sirolimus-Eluting Stent vs Abciximab
Drug-Eluting Stents are second generation stents coated with drugs that interrupt the process of restenosis. Get more info about the stents on Radcliffe Cardiology
» Dual Anti-platelet Therapy after Coronary Stenting: Rationale for Personalized the ACC/AHA guidelines of drug-eluting stent thrombosis in
… receiving drug-eluting stents trials,3 current European guidelines recommend the use of drug-eluting a report of the American College of Cardiology
New ACC/AHA guidelines will curb DAPT duration “The American College of Cardiology and the 3 months for current generation drug-eluting stents,
drug-eluting stent; the efficacy of drug-eluting stents the Journal of the American College of Cardiology reflect the views of the authors and do not
Target Lesion Failure and Stent Thrombosis Target Lesion Failure and Stent Thrombosis Rates Low With SYNERGY. Share this Unlike other drug-eluting stents,
The introduction of the drug-eluting stent (DES) ACC/AHA guidelines for the management of patients with st-elevation myocardial infarction
Timing of Noncardiac Surgery After Coronary Artery Stenting With Bare Metal or Drug-Eluting Stents. In line with the ACC/AHA guidelines,

DAPT Wiki Journal Club

Thrombosis of a drug-eluting stent (DES) is a catastrophic complication. The risk of stent thrombosis (ST) is increased in the perioperative setting and is strongly
ACC: Extra-Long Plavix Course No Guidelines recommend et al “Optimal duration of dual antiplatelet therapy after drug-eluting stent implantation” ACC
The newest 2nd and 3rd generation drug-eluting stents have DAPT guidelines for after Resolute zotarolimus-eluting stent implantation. ACC
Cleveland Clinic Journal of Medicine One-Minute Consult article on noncardiac surgery following the placement of a drug-eluting stent
2016 ACC/AHA guideline focused bare metal stent; DES, drug-eluting stent; This article has been copublished in The Journal of the American College of Cardiology.
Dual antiplatelet therapy (DAPT) limits ischemic complications after percutaneous coronary intervention (PCI) with a drug-eluting stent. Although the
new-generation drug-eluting stents ª 2014 BY THE AMERICAN COLLEGE OF CARDIOLOGY FOUNDATION ISSN 0735-1097 SES = sirolimus-eluting stent(s) ST = stent thrombosis
Benefits and Risks of Extended Dual Antiplatelet Therapy after Everolimus-Eluting Dual Antiplatelet Therapy after Everolimus Stents drug-eluting stents,
WITH the advent of percutaneous coronary intervention (PCI), specifically the bare-metal stent (BMS) and subsequently, the drug-eluting stent (DES), the role of

Noncardiac Surgery for Patients with Coronary Artery Stents


Comparison of Drug-Eluting Balloon Followed by Bare Metal

ACC.org; Guidelines; CME/MOC necessarily represent the views of JACC: Cardiovascular Imaging or the and Two Steps Back With Drug-Eluting-Stents. Gaku
Drug-eluting stents are highly effective in reducing recurrent et al. 2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in
Angioplasty and stent A drug-eluting stent has medicine embedded in it that helps et al. 2014 AHA/ACC guideline for the management of patients with
… stents, and in particular drug-eluting stents for the 2016 ACC/AHA Guideline Focused Update on American College of Cardiology/American Heart
Revision guidelines on surgery after stent implantation needed and case reports of stent thrombosis in patients with drug-eluting stents
Editor—I read with great interest the recent article by Godet and colleagues 1 on drug-eluting stent (DES) thrombosis. Recent literature indicates that barring

For Stable Ischemic Heart Disease Patients Receiving a


Evolution of Drug-Eluting Stent Drug Elution Profile Is a

Objectives We compared the risk of stent thrombosis (ST) after drug-eluting stents (DES) versus bare-metal stents (BMS), and tested the hypothesis that the risk of
Evidence Based Guideline Page 1 of 4 An Independent Licensee of the Blue Cross and Blue Shield Association Drug Eluting Coronary Stent File Name: drug_eluting

Drug-eluting Stents RadcliffeCardiology

Drug-Eluting Stents JACC Journal of the American

Drug-eluting stent thrombosis JACC Journal of the

Benefits and Risks of Extended Dual Antiplatelet Therapy


Evidence Based Guideline Blue Cross NC

Revision guidelines on surgery after stent implantation needed

ACC/AHA Guidelines and Cardiac Stents JAMA
Noncardiac Surgery for Patients with Coronary Artery Stents

Drug-eluting stents may lower the chance that you If you get a drug-eluting stent, . 2016 ACC/AHA Guideline focused update on duration of dual antiplatelet
Timing of Noncardiac Surgery After Coronary Artery Stenting With Bare Metal or Drug-Eluting Stents. In line with the ACC/AHA guidelines,
History of invasive and interventional cardiology The drug eluting stent The FDA advisory board reiterated the ACC guidelines that clopidogrel should be
Target Lesion Failure and Stent Thrombosis Target Lesion Failure and Stent Thrombosis Rates Low With SYNERGY. Share this Unlike other drug-eluting stents,
©emea 2007 page 2/9 guideline on the development of active substances contained in drug-eluting coronary stents table of contents 1. legal basis
Drug-eluting stents are highly effective in reducing recurrent et al. 2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in
An Option to Replace Drug-Eluting Stents. the American College of Cardiology (ACC) treatment guidelines recommend at least 12 months of dual antiplatelet

Drug-eluting Stents RadcliffeCardiology
OCT-Verified Neointimal Hyperplasia Is Increased at

View answers to frequently asked questions about the SYNERGY bioabsorbable polymer stent bioabsorbable polymer drug-eluting stent. ACC/AHA guidelines
Guidelines for the use of antiplatelet therapy in patients with coronary stents of drug eluting stents use of antiplatelet therapy in patients with
Drug-eluting stents may lower the chance that you If you get a drug-eluting stent, . 2016 ACC/AHA Guideline focused update on duration of dual antiplatelet
Twelve Months Dual Antiplatelet Therapy after et al. ACC/AHA 2007 Guidelines et al. Optimal duration of dual antiplatelet therapy after drug-eluting stent
… receiving drug-eluting stents trials,3 current European guidelines recommend the use of drug-eluting a report of the American College of Cardiology
Antiplatelet therapy after placement of a drug-eluting stent: outcomes with drug-eluting stents versus ACC/AHA Guidelines for the Management
The newest 2nd and 3rd generation drug-eluting stents have DAPT guidelines for after Resolute zotarolimus-eluting stent implantation. ACC
Early drug-eluting stent thrombosis shares the same predictors of early bare “ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for
et al. ACC/AHA guidelines for the bolus tirofiban and sirolimus eluting stent versus and Sirolimus-Eluting Stent vs Abciximab
WITH the advent of percutaneous coronary intervention (PCI), specifically the bare-metal stent (BMS) and subsequently, the drug-eluting stent (DES), the role of
Objectives We compared the risk of stent thrombosis (ST) after drug-eluting stents (DES) versus bare-metal stents (BMS), and tested the hypothesis that the risk of

Evolution of Drug-Eluting Stent Drug Elution Profile Is a
Should We Shorten the Duration of Dual Antiplatelet

The newest 2nd and 3rd generation drug-eluting stents have DAPT guidelines for after Resolute zotarolimus-eluting stent implantation. ACC
Although drug-eluting stents ACC.org; Guidelines; and there is no OCT study that clarifies the relationship between stent fracture and neointimal hyperplasia
et al. ACC/AHA guidelines for the bolus tirofiban and sirolimus eluting stent versus and Sirolimus-Eluting Stent vs Abciximab
Evidence Based Guideline Page 1 of 4 An Independent Licensee of the Blue Cross and Blue Shield Association Drug Eluting Coronary Stent File Name: drug_eluting
WITH the advent of percutaneous coronary intervention (PCI), specifically the bare-metal stent (BMS) and subsequently, the drug-eluting stent (DES), the role of
Editor—I read with great interest the recent article by Godet and colleagues 1 on drug-eluting stent (DES) thrombosis. Recent literature indicates that barring
Thrombosis of a drug-eluting stent (DES) is a catastrophic complication. The risk of stent thrombosis (ST) is increased in the perioperative setting and is strongly
History of invasive and interventional cardiology The drug eluting stent The FDA advisory board reiterated the ACC guidelines that clopidogrel should be
Guidelines for the use of antiplatelet therapy in patients with coronary stents of drug eluting stents use of antiplatelet therapy in patients with
Data with regard to potential advantages and pitfalls in drug-eluting stent Antiplatelet Therapy in the Era of Drug-Eluting Guidelines. ACC/AHA
Antiplatelet therapy after placement of a drug-eluting stent: outcomes with drug-eluting stents versus ACC/AHA Guidelines for the Management
… prevention of which has been achieved with the development of drug-eluting stents. FDA/American college of cardiology ACC/AHA 2007 guidelines on
Drug-Eluting Stents are second generation stents coated with drugs that interrupt the process of restenosis. Get more info about the stents on Radcliffe Cardiology
Cleveland Clinic Journal of Medicine One-Minute Consult article on noncardiac surgery following the placement of a drug-eluting stent
Target Lesion Failure and Stent Thrombosis Target Lesion Failure and Stent Thrombosis Rates Low With SYNERGY. Share this Unlike other drug-eluting stents,

Guideline on drug eluting stents European Medicines Agency
Noncardiac Surgery for Patients with Coronary Artery Stents

Noncardiac Surgery for Patients with Coronary drug-eluting stents after cardiac surgery 12 and current AHA/ACC guidelines recommend discontinuing its
Patients with coronary artery disease who received an Endeavor or Resolute drug-eluting stent from Medtronic Inc. and subsequently interrupted their dual antiplatelet
Thrombosis of a drug-eluting stent (DES) is a catastrophic complication. The risk of stent thrombosis (ST) is increased in the perioperative setting and is strongly
Practice Alert for the Perioperative Management of Patients with Coronary Artery ion is also supported by the ACC/AHA Guidelines on Drug-eluting stents:
View answers to frequently asked questions about the SYNERGY bioabsorbable polymer stent bioabsorbable polymer drug-eluting stent. ACC/AHA guidelines
Graham et al examine the effect of the revised American College of Cardiology/American Heart Association (ACC/AHA) guidelines on with drug-eluting stents

Drug-Eluting Stents for ST-Segment Elevation Myocardial
Drug-Eluting Stents HealthLink BC

Angioplasty and stent A drug-eluting stent has medicine embedded in it that helps et al. 2014 AHA/ACC guideline for the management of patients with
Clinical Guidelines for the Use of Drug Eluting Coronary Drug eluting stents have been found to be superior to balloon (ACC/AHA) update for
drug-eluting stent; the efficacy of drug-eluting stents the Journal of the American College of Cardiology reflect the views of the authors and do not
Test yourself with Question of the Week: until 6 months after the drug-eluting stent placement. The ACC/AHA ACC guideline for the management of
Second-generation drug-eluting stent a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Comparison of Drug-Eluting Balloon Followed by Bare Metal
Target Lesion Failure and Stent Thrombosis Rates Low With

Twelve Months Dual Antiplatelet Therapy after et al. ACC/AHA 2007 Guidelines et al. Optimal duration of dual antiplatelet therapy after drug-eluting stent
Second-generation drug-eluting stent a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
drug-eluting stent; the efficacy of drug-eluting stents the Journal of the American College of Cardiology reflect the views of the authors and do not
Editor—I read with great interest the recent article by Godet and colleagues 1 on drug-eluting stent (DES) thrombosis. Recent literature indicates that barring

Drug-eluting stent thrombosis in patients undergoing non
OCT-Verified Neointimal Hyperplasia Is Increased at

Evidence Based Guideline Page 1 of 4 An Independent Licensee of the Blue Cross and Blue Shield Association Drug Eluting Coronary Stent File Name: drug_eluting
… some patients received a drug-eluting stent (DES) (CAD). 9,10,21 The “2016 American College of Cardiology (ACC et al. 2014 AHA/ACC guideline for the
Early drug-eluting stent thrombosis shares the same predictors of early bare “ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for
The use of drug-eluting stents (DES) for primary percutaneous coronary intervention (PCI) for ST-segment elevation myocardial infarction (STEMI) has generated a
Drug-eluting stents may lower the chance that you If you get a drug-eluting stent, . 2016 ACC/AHA Guideline focused update on duration of dual antiplatelet

Benefits and Risks of Extended Dual Antiplatelet Therapy
Angioplasty and stent placement heart MedlinePlus

Benefits and Risks of Extended Dual Antiplatelet Therapy after Everolimus-Eluting Dual Antiplatelet Therapy after Everolimus Stents drug-eluting stents,
Second-generation drug-eluting stent a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
Background. The optimal duration of dual antiplatelet therapy (DAPT) after implantation of newer-generation drug-eluting stents (DES) remains uncertain.
Practice Alert for the Perioperative Management of Patients with Coronary Artery ion is also supported by the ACC/AHA Guidelines on Drug-eluting stents:
… prevention of which has been achieved with the development of drug-eluting stents. FDA/American college of cardiology ACC/AHA 2007 guidelines on
Antiplatelet therapy after placement of a drug-eluting stent: outcomes with drug-eluting stents versus ACC/AHA Guidelines for the Management
WITH the advent of percutaneous coronary intervention (PCI), specifically the bare-metal stent (BMS) and subsequently, the drug-eluting stent (DES), the role of
Test yourself with Question of the Week: until 6 months after the drug-eluting stent placement. The ACC/AHA ACC guideline for the management of
ACC: Extra-Long Plavix Course No Guidelines recommend et al “Optimal duration of dual antiplatelet therapy after drug-eluting stent implantation” ACC
An Option to Replace Drug-Eluting Stents. the American College of Cardiology (ACC) treatment guidelines recommend at least 12 months of dual antiplatelet

Drug-eluting stent thrombosis in patients undergoing non
Target Lesion Failure and Stent Thrombosis Rates Low With

How Long Should Plavix be Used After Coronary Stenting ACC/AHA guidelines. Both the drug-eluting stents and American College of Cardiology
Data with regard to potential advantages and pitfalls in drug-eluting stent Antiplatelet Therapy in the Era of Drug-Eluting Guidelines. ACC/AHA
et al. ACC/AHA guidelines for the bolus tirofiban and sirolimus eluting stent versus and Sirolimus-Eluting Stent vs Abciximab
Objectives We compared the risk of stent thrombosis (ST) after drug-eluting stents (DES) versus bare-metal stents (BMS), and tested the hypothesis that the risk of
Target Lesion Failure and Stent Thrombosis Target Lesion Failure and Stent Thrombosis Rates Low With SYNERGY. Share this Unlike other drug-eluting stents,
The newest 2nd and 3rd generation drug-eluting stents have DAPT guidelines for after Resolute zotarolimus-eluting stent implantation. ACC
ACC.org; Guidelines; CME/MOC necessarily represent the views of JACC: Cardiovascular Imaging or the and Two Steps Back With Drug-Eluting-Stents. Gaku

Drug-Eluting Stents HealthLink BC
Drug-Eluting or Bare-Metal Stents for Coronary Artery

new-generation drug-eluting stents ª 2014 BY THE AMERICAN COLLEGE OF CARDIOLOGY FOUNDATION ISSN 0735-1097 SES = sirolimus-eluting stent(s) ST = stent thrombosis
Objectives We compared the risk of stent thrombosis (ST) after drug-eluting stents (DES) versus bare-metal stents (BMS), and tested the hypothesis that the risk of
drug-eluting stent; the efficacy of drug-eluting stents the Journal of the American College of Cardiology reflect the views of the authors and do not
The introduction of the drug-eluting stent (DES) ACC/AHA guidelines for the management of patients with st-elevation myocardial infarction
WITH the advent of percutaneous coronary intervention (PCI), specifically the bare-metal stent (BMS) and subsequently, the drug-eluting stent (DES), the role of
Drug-eluting stents prevent a coronary artery from If you get a drug-eluting stent, . 2016 ACC/AHA Guideline focused update on duration of dual antiplatelet
Evidence Based Guideline Page 1 of 4 An Independent Licensee of the Blue Cross and Blue Shield Association Drug Eluting Coronary Stent File Name: drug_eluting
Drug-eluting stents are intended to have lower rates of late restenosis Guidelines. ACC/AHA DAPT in Journal of the American College of Cardiology

Drug-eluting stents versus bare-metal stents in acute
Tirofiban and Sirolimus-Eluting Stent vs Abciximab and

… some patients received a drug-eluting stent (DES) (CAD). 9,10,21 The “2016 American College of Cardiology (ACC et al. 2014 AHA/ACC guideline for the
et al. ACC/AHA guidelines for the bolus tirofiban and sirolimus eluting stent versus and Sirolimus-Eluting Stent vs Abciximab
Benefits and Risks of Extended Dual Antiplatelet Therapy after Everolimus-Eluting Dual Antiplatelet Therapy after Everolimus Stents drug-eluting stents,
… prevention of which has been achieved with the development of drug-eluting stents. FDA/American college of cardiology ACC/AHA 2007 guidelines on
The newest 2nd and 3rd generation drug-eluting stents have DAPT guidelines for after Resolute zotarolimus-eluting stent implantation. ACC
Practice Alert for the Perioperative Management of Patients with Coronary Artery ion is also supported by the ACC/AHA Guidelines on Drug-eluting stents:
How Long Should Plavix be Used After Coronary Stenting ACC/AHA guidelines. Both the drug-eluting stents and American College of Cardiology
View answers to frequently asked questions about the SYNERGY bioabsorbable polymer stent bioabsorbable polymer drug-eluting stent. ACC/AHA guidelines
… receiving drug-eluting stents trials,3 current European guidelines recommend the use of drug-eluting a report of the American College of Cardiology
Drug-eluting stents prevent a coronary artery from If you get a drug-eluting stent, . 2016 ACC/AHA Guideline focused update on duration of dual antiplatelet
Although drug-eluting stents ACC.org; Guidelines; and there is no OCT study that clarifies the relationship between stent fracture and neointimal hyperplasia
Angioplasty and stent A drug-eluting stent has medicine embedded in it that helps et al. 2014 AHA/ACC guideline for the management of patients with

Drug-Eluting or Bare-Metal Stents for Coronary Artery
ACC/AHA Guidelines and Cardiac Stents JAMA

Test yourself with Question of the Week: until 6 months after the drug-eluting stent placement. The ACC/AHA ACC guideline for the management of
new-generation drug-eluting stents ª 2014 BY THE AMERICAN COLLEGE OF CARDIOLOGY FOUNDATION ISSN 0735-1097 SES = sirolimus-eluting stent(s) ST = stent thrombosis
» Dual Anti-platelet Therapy after Coronary Stenting: Rationale for Personalized the ACC/AHA guidelines of drug-eluting stent thrombosis in
Noncardiac Surgery for Patients with Coronary drug-eluting stents after cardiac surgery 12 and current AHA/ACC guidelines recommend discontinuing its
Data with regard to potential advantages and pitfalls in drug-eluting stent Antiplatelet Therapy in the Era of Drug-Eluting Guidelines. ACC/AHA
History of invasive and interventional cardiology The drug eluting stent The FDA advisory board reiterated the ACC guidelines that clopidogrel should be

Stent Thrombosis in New-Generation Drug-Eluting Stents in
OCT-Verified Neointimal Hyperplasia Is Increased at

Noncardiac Surgery for Patients with Coronary drug-eluting stents after cardiac surgery 12 and current AHA/ACC guidelines recommend discontinuing its
ACC.org; Guidelines; CME/MOC necessarily represent the views of JACC: Cardiovascular Imaging or the and Two Steps Back With Drug-Eluting-Stents. Gaku
… receiving drug-eluting stents trials,3 current European guidelines recommend the use of drug-eluting a report of the American College of Cardiology
Patients with coronary artery disease who received an Endeavor or Resolute drug-eluting stent from Medtronic Inc. and subsequently interrupted their dual antiplatelet
Cleveland Clinic Journal of Medicine One-Minute Consult article on noncardiac surgery following the placement of a drug-eluting stent
Drug-eluting stents are highly effective in reducing recurrent et al. 2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in
Twelve Months Dual Antiplatelet Therapy after et al. ACC/AHA 2007 Guidelines et al. Optimal duration of dual antiplatelet therapy after drug-eluting stent
new-generation drug-eluting stents ª 2014 BY THE AMERICAN COLLEGE OF CARDIOLOGY FOUNDATION ISSN 0735-1097 SES = sirolimus-eluting stent(s) ST = stent thrombosis
… stents, and in particular drug-eluting stents for the 2016 ACC/AHA Guideline Focused Update on American College of Cardiology/American Heart
Duration of Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation in Patients With and Without Acute Coronary Syndrome A Systematic Review of Randomized
Drug-eluting stents are intended to have lower rates of late restenosis Guidelines. ACC/AHA DAPT in Journal of the American College of Cardiology

Tirofiban and Sirolimus-Eluting Stent vs Abciximab and
History of invasive and interventional cardiology Wikipedia

drug-eluting stent; the efficacy of drug-eluting stents the Journal of the American College of Cardiology reflect the views of the authors and do not
» Dual Anti-platelet Therapy after Coronary Stenting: Rationale for Personalized the ACC/AHA guidelines of drug-eluting stent thrombosis in
Early drug-eluting stent thrombosis shares the same predictors of early bare “ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for
Angioplasty and stent A drug-eluting stent has medicine embedded in it that helps et al. 2014 AHA/ACC guideline for the management of patients with